
THC medication reduces PTSD nightmares in clinical trial
The story in brief
A clinical trial found that Dronabinol, a cannabis-derived medication containing THC, significantly reduced trauma-related nightmares in over 170 adults with PTSD. While it improved nightmare frequency and sleep quality, it did not reduce overall PTSD severity. The study, published in Nature Medicine, highlights a potential new treatment for trauma-related nightmares in Germany, where no specific medications currently exist for this condition.